91
Views
6
CrossRef citations to date
0
Altmetric
Hemoglobinopathy

Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major

, &
Pages 77-82 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Adriana Ceci, Rosa Conte, Antonella Didio, Donato Bonifazi, Mariagrazia Felisi, Viviana Giannuzzi & Fedele Bonifazi. (2019) An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload. Expert Opinion on Orphan Drugs 7:4, pages 181-197.
Read now

Articles from other publishers (5)

Elisa Borella, Sean Oosterholt, Paolo Magni & Oscar Della Pasqua. (2022) Characterisation of individual ferritin response in patients receiving chelation therapy. British Journal of Clinical Pharmacology 88:8, pages 3683-3694.
Crossref
A. Arya, S. Jokar, P. Etemadfar, J.M. Malekzadeh, R. Jannesar, M. Rohani, T. Mohamadi, F. Kharaman, M. Yosefi & A. Roozbehi. (2020) Comparison of Deferoxamine, Deferiprone and Deferasirox Iron-Chelating Agents in Reducing Serum Ferritin Levels in Patients with Thalassemia Major. Journal of Clinical Care and Skills 1:4, pages 189-193.
Crossref
Sneha Dadheech, A. Venkateswara Rao, Uzma Shaheen, Mohammed Dyia Hussien, Suman Jain, A. Jyothy & Anjana Munshi. (2013) Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Serand Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients. Gene 531:2, pages 301-305.
Crossref
John B. Porter & Farrukh T. Shah. (2010) Iron Overload in Thalassemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies. Hematology/Oncology Clinics of North America 24:6, pages 1109-1130.
Crossref
Inusha Panigrahi, Ram K. Marwaha, Rashmi R. Das, Amita Trehan & Deepak Bansal. (2009) Long-term response to deferiprone therapy in Asian Indians. Annals of Hematology 89:2, pages 135-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.